Search Results

11 Results found for "bill gates"

Result pages:1 | 2

1. USask VIDO-InterVac expands international role to test antiviral compounds against COVID-19

The Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) at the University of Saskatchewan (USask) has been awarded a grant of almost $830,000 from the COVID-19 Therapeutics...

2. USask VIDO-InterVac expands international role to test antiviral compounds against COVID-19

The Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) at the University of Saskatchewan (USask) has been awarded a grant of almost $830,000 from the COVID-19 Therapeutics...

3. VIDO-InterVac Major Partner in HIV/AIDS Vaccine Pilot Plant Bid

In March, the International Centre for Infectious Diseases (ICID) in Winnipeg submitted its full proposal for the Canadian HIV Vaccine Initiative (CHVI), a joint project of the Government of Canada and...

4. Frequently Asked Questions

1. What type of vaccine is VIDO developing? We are developing subunit vaccines. Subunit vaccines contain purified viral proteins (an antigen) that are not infectious, and often also contain an adjuvant...

5. Volker Gerdts Named as New VIDO-InterVac Director and CEO

Following an international search, Dr. Volker Gerdts has been selected to lead the University of Saskatchewan’s Vaccine and Infectious Disease Organization-International Vaccine Centre, a world leader...

6. International Centre for Infectious Diseases Names New Board Chair

(ICID release)A new Chair has been selected by the Board of Directors of the International Centre for Infectious Diseases (ICID). Dr. Lorne Babiuk, Director and CEO of Saskatoon’s Vaccine and Infectious...

7. VIDO-InterVac signs exclusive license agreement for developing a novel vaccine against Respiratory Syncytial Virus

SASKATOON - The Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) at the University of Saskatchewan announced today the signing of an exclusive license agreement...

8. New Associate Director of Research Named

We are pleased to announce that Dr. Volker Gerdts will become the new Associate Director of Research at the University of Saskatchewan’s VIDO/InterVac starting July 1.Dr. Gerdts leads VIDO’s Neonatal...

9. Paul Hodgson

Dr. Paul Hodgson joined the VIDO senior management team in 2006. He is responsible for business development, marketing and communications.  Prior to joining VIDO, Dr. Hodgson managed several multi-million...

10. Maternal Immunization May Protect Newborns from Whooping Cough U of S VIDO Study

In a bid to find a way to protect newborns from whooping cough, a research team at the University of Saskatchewan’s Vaccine and Infectious Disease Organization (VIDO) has shown that vaccinating pregnant...

Result pages:1 | 2